US Patent Issued to International AIDS Vaccine Initiative, The Scripps Research Institute on April 22 for "Recombinant HIV Env polypeptides and their use" (California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,142, issued on April 22, was assigned to International AIDS Vaccine Initiative Inc. (New York) and The Scripps Research Institute (La Jolla, Calif.).

"Recombinant HIV Env polypeptides and their use" was invented by Jon M. Steichen (La Jolla, Calif.) and William R. Schief (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to recombinant HIV Env polypeptides and their use in the treatment and prevention of HIV/AIDS."

The patent was filed on June 1, 2021, under Application No. 17/335,244.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?S...